VTRS
Viatris Inc
NASDAQ: VTRS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$18.77
+0.27% today
Updated 2026-10-28
Market cap
$21.43B
P/E ratio
—
P/S ratio
1.45x
EPS (TTM)
$-0.36
Dividend yield
2.63%
52W range
$10 – $19
Volume
8.4M
Viatris Inc (VTRS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$18.77
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$8.84
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.9B | $16.3B | $15.4B | $14.7B | $14.3B | $14.8B | $15.4B | $15.9B | $16.5B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 3.66% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -2.79%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.